- Home
- CCBG vs DCTH Comparison
CCBG vs DCTH Comparison
Compare CCBG & DCTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCBG
- DCTH
- Stock Information
- Founded
- CCBG 1895
- DCTH 1988
- Country
- CCBG United States
- DCTH United States
- Employees
- CCBG N/A
- DCTH N/A
- Industry
- CCBG Major Banks
- DCTH Medical/Dental Instruments
- Sector
- CCBG Finance
- DCTH Health Care
- Exchange
- CCBG Nasdaq
- DCTH Nasdaq
- Market Cap
- CCBG 647.6M
- DCTH 630.4M
- IPO Year
- CCBG N/A
- DCTH N/A
- Fundamental
- Price
- CCBG $36.90
- DCTH $13.85
- Analyst Decision
- CCBG Buy
- DCTH Strong Buy
- Analyst Count
- CCBG 2
- DCTH 4
- Target Price
- CCBG $39.00
- DCTH $24.00
- AVG Volume (30 Days)
- CCBG 27.2K
- DCTH 508.4K
- Earning Date
- CCBG 07-22-2025
- DCTH 08-04-2025
- Dividend Yield
- CCBG 2.60%
- DCTH N/A
- EPS Growth
- CCBG 11.98
- DCTH N/A
- EPS
- CCBG 3.37
- DCTH N/A
- Revenue
- CCBG $236,037,000.00
- DCTH $53,850,000.00
- Revenue This Year
- CCBG $10.45
- DCTH $155.42
- Revenue Next Year
- CCBG $3.50
- DCTH $37.93
- P/E Ratio
- CCBG $10.88
- DCTH N/A
- Revenue Growth
- CCBG 6.63
- DCTH 1068.87
- 52 Week Low
- CCBG $26.40
- DCTH $7.17
- 52 Week High
- CCBG $40.86
- DCTH $18.23
- Technical
- Relative Strength Index (RSI)
- CCBG 46.80
- DCTH 37.03
- Support Level
- CCBG $35.94
- DCTH $15.72
- Resistance Level
- CCBG $37.64
- DCTH $17.35
- Average True Range (ATR)
- CCBG 0.87
- DCTH 0.74
- MACD
- CCBG -0.16
- DCTH -0.40
- Stochastic Oscillator
- CCBG 31.68
- DCTH 2.23
About CCBG Capital City Bank Group
Capital City Bank Group Inc is a United States-based group engaged in Banking services, Trust and asset management services, and Brokerage services. The company operates in one segment with two principal services: Banking Services and Wealth Management Services. It offers retail and commercial banking business in the form of traditional deposit and credit services, asset management, trust, mortgage banking, merchant services, bank cards, data processing, and securities brokerage services among others through its banking offices in Florida, Georgia, and Alabama.
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. The company operates in one reportable segment which includes the research, development, manufacture, and distribution of hepatic delivery systems for use in the treatment of specific conditions. The Company operates its business in the United States and Europe.